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Natural hosts of simian immunodeficiency virus (SIV), African greenmonkeys (AGMs), rarely transmit SIV via breast-feeding.
In order to examine the genetic diversity of breast milk SIV variants in this limited-transmission setting, we performed phyloge-
netic analysis on envelope sequences of milk and plasma SIV variants of AGMs. Low-diversity milk virus populations were com-
partmentalized from that in plasma. However, this compartmentalization was transient, as the milk virus lineages did not per-
sist longitudinally.
Postnatal human immunodeficiency virus type 1 (HIV-1)transmission via breast-feeding results in nearly half of the
330,000 infant infections occurring annually (1). Interruption of
this mode of infant HIV-1 transmission is key to achieving an
HIV-free generation. Interestingly, natural primate hosts of sim-
ian immunodeficiency virus (SIV), who coevolved with the virus
for thousands of years and sustain a nonpathogenic infection, ap-
pear to transmit the virus to their infants postnatally only rarely
(2–6). This negligible rate of SIV transmission via breast-feeding
in natural SIV hosts contrasts with that of nonnatural SIV hosts,
rhesus macaques, who transmit SIV via breast-feeding at a high
rate (7). Understanding the mechanisms underlying the rarity of
breast milk transmission in natural hosts of SIV could guide the
development of interventions to impede postnatal HIV-1 trans-
mission.
In humans, high plasma and milk viral loads are associated
with the risk of breast milk transmission of HIV (8). However, in
natural SIV hosts, African green monkeys (AGMs) (Chlorocebus
sabaeus), breast milk viral loads are similar to that of rhesus mon-
keys, suggesting that the low rate of postnatal transmission of SIV
in AGMs is not a result of lowmilk virus content (9). A low num-
ber of CCR5-expressing CD4 target cells in infant AGMs (5) and
sooty mangabeys (A. Chahroudi, E. Cartwright, D. G. Carnathan,
S. T. Lee, B. Lawson, P. M. Carnathan, T. Hashempoor, M. K.
Murphy, T. Meeker, S. Ehnert, C. Souder, J. G. Else, J. Cohen,
T.H.Vanderford, S. R. Permar, C. A.Derdeyn, F. Villinger, andG.
Silvestri, submitted for publication), another natural host species,
has also been suggested as a key factor in the low infant infection
rate. On the other hand, the strong neutralizing-antibody re-
sponse observed in breast milk of AGMs (9) is a possible mecha-
nism for the prevention of postnatal virus transmission in the
natural hosts of SIV as it contrasts with the limited virus neutral-
ization response detected in the milk of rhesus monkeys (9) and
humans (10). Neutralizing antibodies are directed toward and
exert selective pressure on the virus Envelope (Env) glycoprotein
(11), the key determinant of host-cell interactions and neutraliza-
tion sensitivity (12, 13). However, the role of neutralizing-anti-
body and neutralization escape mutants in postnatal HIV/SIV
transmission remains unclear (14, 15). Thus, the role of local hu-
moral immune responses and virus env evolution in the breast
milk of the natural SIV hosts warrants further investigation.
Breastmilk is separated from the systemic compartment by the
mammary epithelium, which tightly regulates breast milk content
(16). Therefore, it is possible that breast milk represents a distinct
virologic compartment, which is characterized by the restriction
of viral gene flow between tissues (17). Our previous studies in
humans and rhesus monkeys, nonnatural hosts of HIV/SIV, re-
vealed that milk virus variants exhibit limited compartmentaliza-
tion from plasma virus variants (18, 19). However, whereas the
breast milk viral load in humans and rhesus monkeys is 1 to 2 logs
lower than that of plasma (19, 20), milk and plasma viral loads in
AGMs are similar (9). This finding suggests distinct virus origins
and replicationmechanisms in breastmilk of natural and nonnat-
ural SIV hosts. Experimental infection of AGMs with an endemic
SIV strain is a robust model for studying virus populations and
immune responses in natural hosts of SIV (21). To study the milk
virus population in natural SIV hosts, we inoculated pharmaco-
logically induced lactating AGMs (20) and evaluated their sys-
temic and breast milk virus populations to determine if natural
SIV hosts harbor a distinct virus population in breast milk. Anal-
ysis of the virus population in milk of AGMs may provide insight
on mechanisms that evolved to limit infant acquisition of SIV in
natural hosts and has implications for the design of immunologic
strategies to prevent postnatal transmission of HIV.
Compartmentalization of breast milk virus variants from
the plasma virus population in AGMs chronically infected with
a swarm SIVsab virus stock. We performed single-genome am-
plification, sequencing, and maximum-likelihood phylogenetic
analysis on milk and plasma env virus sequences from two lactat-
ing AGMs 3 years following intravenous inoculation with the het-
erogeneous uncloned SIVsab9351BR virus stock (Fig. 1) (9). Viral
RNA was extracted from plasma and milk, reverse transcribed
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into cDNA, and amplified by single-genome amplification, a
method which reduces the likelihood of Taq-induced recombina-
tion and template resampling (18, 19, 22, 23). A nested PCR was
performed on endpoint diluted-cDNA using the following prim-
ers: outer forward (5=-GTGGGTGTTGGAGCTTAGTGTGG-3=),
outer reverse (5=-CCATCTCTCAAGCTCTTGGCGC-3=), inner
forward (5=-GTTGGAGCTTAGTGTGGTTAGTCC-3=), and in-
ner reverse (5=-GGCGCATTCTTCTTGGATGTG-3=). Amino
acid sequences were aligned using MUSCLE (24), and the result-
ing amino acid alignment was back-translated into the corre-
sponding DNA sequence alignment. Maximum-likelihood trees
of plasma andmilk virus env sequences were constructed through
PAUP* (25), applying the general time-reversible (GTR) substi-
tution model with fixed gamma-distributed rate variation across
sites.
Interestingly, the sequenced milk env variants generally clus-
tered on branches distinct from those in plasma on phylogenetic
analysis (Fig. 1). We applied the Slatkin-Maddison test of com-
partmentalization, a test that compares the minimum possible
number of intercompartmentmigration events to the distribution
of migration events in 10,000 randomized trees. Using this statis-
tical test, there was statistical evidence of milk and plasma virus
compartmentalization in both monkeys 361 (P  0.01) and 365
(P 0.0004).
Acute infection of lactating AGMs with an infectious molec-
ular clone T/F SIVsab variant.While we observed compartmen-
talization of breast milk and plasma virus variants in two AGMs 3
years after intravenous infection with an SIV stock consisting of a
swarm of viral quasispecies, this model is not representative of the
typical mucosal HIV/SIV infection that is initiated by a single or
small number of transmitter/founder (T/F) variants (23). Thus,
we utilized a previously defined species-specific infectious molec-
ular clone T/F SIV variant (SIVsab92018ivTF) to intravenously
infect six female hormone-induced lactating AGMs as previously
described (26) (500 ng of p27; TZM-bl 50% tissue culture infec-
tious dose, 2.6 106). This model of cloned T/F SIV infection is
advantageous for defining viral sequence evolution but also has its
limitations, as intravenous infection is not representative of the
likely more common mucosal route of SIV infection in this spe-
cies. As CD4 T lymphocytes in breast milk are likely to facilitate
replication of SIV within the breast milk compartment, we first
sought to quantify and compare percentages and absolute num-
bers of CD4 T cells in the blood and breast milk following infec-
tion. The proportion of CD4 T lymphocytes was considerably
lower in breast milk cells (range, 0 to 3.2%; Fig. 2B) than in blood
(range, 10.9 to 26.7%; Fig. 2A) of SIV-infected AGMs. Similarly,
the absolute CD4 T cell count was considerably lower in breast
milk (range, 0 to 5 cells/l; Fig. 2D) than in blood (range, 109 to
881 cells/l; Fig. 2C). The low level of CD4 T cells present in
breast milk of these AGMs may be a result of the downregulation
of CD4 on naive CD4 T cells upon transition to memory cells
(27). However, despite the low number of CD4 T lymphocyte
target cells in breast milk of all SIV-infected AGMs, the peakmea-
sured milk viral load at 14 days postinfection (median, 5.3 104
copies/ml; range, 6.1 102 to 12.2 104 copies/ml) was similar to
that in plasma (median, 4.3 104 copies/ml; range, 2.9 104 to
9.2  104 copies/ml; P  0.93; Fig. 2E), with only two of six
monkeys having considerably lower milk virus load than plasma
virus load. As samples were collected only at 7 days and 14 days
postinfection, the peak of viremia may have been missed in the
two monkeys with lower-than-expected peak viral loads. The set
point viral load in breast milk at 50 days postinfection in animals
with adequate milk sample for virus load assessment (n 4) (me-
dian, 5.6 102 copies/ml; range, 4.2 102 to 1.4 103 copies/ml)
even trended toward slightly higher values than that of plasma
(median, 3.3 102 copies/ml; range, 2.5 102 to 4.4 102 copies/
ml; P 0.09). Although the viral loads observed in this study were
low compared to those determined in prior studies in AGMs (9,
26), the kinetics of viremia followed an expected course, and the
finding that plasma and breast milk viral loads are of similar mag-
nitudes throughout infection is consistent with results from our
previously reported study (9).
Compartmentalization of breast milk virus variants from
the plasma virus population at 5months post-T/F SIV infection
in AGMs. We next investigated SIVsab env sequences of virus
variants inmilk and blood of five of the sixAGMs infectedwith the
FIG 1 Maximum-likelihood trees of plasma and breast milk virus variants of AGMs 3 years after infection with an uncloned SIVsab virus stock. The trees show
full-length SIV env sequences amplified by single-genome amplification from plasma (red squares) and milk (blue circles). There is evidence of compartmen-
talization between breast milk and plasma virus variants. The P values were generated by the Slatkin-Maddison test of compartmentalization. The scale bars
represent 0.003 substitutions per site.
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cloned T/F variant. Monkey 90 was excluded from analysis as
there was insufficient breastmilk to extract viral RNA. Primers for
SIVsab92018ivTF single-genome amplification included the fol-
lowing: outer forward (5=-CCGCATATGGCCCAGGAAGAG-
3=), outer reverse (5=-CACAATTCCCCACTCATTAAGAG-3=),
inner forward (5=-ATGCTGCTATCATTGTCCGCTT-3=), and
inner reverse (5=-ATTACCCTCAGAGGTACCCTG-3=). Se-
quences with nonsense mutations were removed from statistical
analysis, and a region corresponding to amino acids 123 to 131
(ASKTSKTT) in the SIVSab92018 T/F env clone was removed
from the multiple-sequence alignment of the monkey 92 data be-
cause substitutions and multiple amino acid insertions in that
region generated an ambiguous alignment. The maximum-likeli-
hood trees of plasma and milk virus env sequences revealed clus-
tering of milk virus variants separately from those in plasma in
four of five monkeys (Fig. 3). In contrast to the other four mon-
keys, the plasma andmilk virus variants inmonkey 93were largely
interspersed throughout the phylogenetic tree. The four monkeys
that displayed little to no intermingling of the plasma and breast
milk virus variants (monkeys 89, 91, 92, and 94) showed statistical
evidence of phylogenetic compartmentalization between blood
and milk virus variants by the Slatkin-Maddison test (P value
range, P  0.0001 to P  0.001). However, the low genetic dis-
tance from the breastmilk virus variants to theirmost recent com-
mon ancestor compared to that of plasma variants inmonkeys 89,
92, and 94 suggested limited evolution of milk virus variants
within themammary gland (data not shown). Furthermore, there
did not appear to be differences in the pairwise distances of the
plasma and breast milk virus variants from the challenge virus
sequence within any of the five AGMs (data not shown), indicat-
ing that the breast milk and plasma virus variants evolved at sim-
ilar rates.
Local replication of virus variants in the breast milk com-
partment of SIV-infected AGMs. In humans and rhesus mon-
keys, groups of identical HIV/SIV env variants were more com-
mon in milk than in blood, indicating the local production of
virus (18, 19). In this study, three (monkeys 89, 91, and 92) of the
four monkeys that displayed statistical evidence of compartmen-
talization by the Slatkin-Maddison test demonstratedmilk viruses
that clustered in large groups of identical or nearly identical se-
quences, suggesting clonal amplification of virus variants that
seeded the breast milk compartment from blood. These large
numbers of identical sequences can inflate statistical measures of
compartmentalization. However, the compartmentalization ob-
served in the two AGMs infected with an uncloned SIVsab virus
stock (Fig. 1) and in monkey 94 (Fig. 3) did not include identical
breast milk env sequences. Furthermore, we repeated the Slatkin-
Maddison test on the data sets of monkeys 89, 91, and 92 after
removing identical sequences within the same compartment.
Monkeys 89 and 91 retained statistical evidence of compartmen-
talization (P 0.01 and P 0.003), and yet statistical evidence of
compartmentalization was lost in monkey 92 (P  1), who had
only two clonal virus species amplified from milk. Thus, after
monotypic sequences were removed, 3 of 5 (60%) monkeys ex-
hibited evidence of compartmentalization, and yet the power of
this Slatkin-Maddison test was reduced because so few breastmilk
sequences remained after removal of the identical sequences.
Fisher’s exact test revealed that the number of identical se-
quences in breast milk was significantly greater than that in
plasma for two (monkeys 91 and 92) of the five AGMs (Table 1).
Overall, the frequency of identical plasma sequences observed in
these monkeys is consistent with those expected based on the
number of identical sequences observed in chronically infected
HIV subjects (19, 28, 29). However, as there were deletions and
insertions among the virus variants in a region that was removed
for sequence alignment in monkey 92, the number of identical
plasma sequences and the number of identical breast milk se-
quences may be inflated in this animal (Fig. 3). Nevertheless, the
FIG 2 CD4 T cell counts and viral loads in blood and breast milk of AGMs acutely infected with a T/F SIVsab variant. (A and B) Percentages of CD4 T
lymphocytes in blood (A) and breast milk (B) from six AGMs during acute infection with SIVsab92018ivTF. (C and D) Absolute CD4 T cell counts in blood (C)
and breast milk (D) during acute infection with SIVSab92018ivTF. (E) The peak SIV viral load in plasma (closed symbols) is similar to that in breast milk (open
symbols) of four SIV-infected AGMs (P 0.93), whereas the set point milk viral load trends toward a magnitude higher than that in plasma (P 0.09). Dashed
lines are drawn between plasma andmilk viral loads from the samemonkey, and solid horizontal lines display themedians of each data set. The dotted horizontal
line represents the minimum of detection in the virus load assay.
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large number of identical sequences in the breast milk compart-
ment of these monkeys suggests that a restricted number of
plasma viruses traffic to the breast milk compartment, where they
are clonally amplified. If this is correct, then compartmentaliza-
tion is not a consequence of an independent, evolving subpopu-
lation of viruses in the breast but is rather an effect of a short-lived
expansion of migratory viruses or infected cells.
Persistent seeding of the breast milk compartment from the
systemic virus population and transient compartmentalization
of breast milk virus variants in SIV-infected AGMs. To assess
whether there is independent evolution of breast milk virus lin-
eages as a result of selective pressure in the breast milk com-
partment or whether compartmentalization of breast milk vi-
rus variants is transient, we amplified and sequenced env
variants from two AGMs infected with the cloned T/F variant 1
year after infection with SIVsab92018ivTF. Compartmental-
ization of milk virus variants was again demonstrated via the
Slatkin-Maddison test at 1 year postinfection in these two
monkeys (P  0.0004 for both). Maximum-likelihood trees of
plasma and milk SIV env variants isolated from 5 months and 1
year postinfection show that milk virus variants were most
closely related to the concurrent plasma virus population (Fig.
4). As the breast milk virus lineages observed at 5 months
postinfection did not persist at 1 year postinfection, the milk
virus variants did not evolve as a distinct viral population over
time. Moreover, groups of identical breast milk virus variants
FIG 3 Compartmentalization of SIVsab92018ivTF env variants in breast milk of four of five AGMs at 5 months postinfection. Maximum-likelihood trees of
full-length SIV env sequences amplified by single-genome amplification fromplasma (red squares) andmilk (blue circles) are shown. TheP valueswere generated
by the Slatkin-Maddison test of compartmentalization. The scale bars represent 0.0005 nuclear substitutions per site. WT, wild type.
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present at 1 year postinfection were distinct from those present
at 5 months postinfection. Thus, virus variants from the pe-
riphery are likely continually trafficking to the breast milk
compartment and undergoing clonal amplification, producing
transient breast milk virus lineages.
This phenomenonof persistent seeding of the breastmilk com-
partment and subsequent clonal replication of virus variants is
similar to that found in SIV-infected rhesus monkeys and HIV-
infectedwomen (18, 19, 29).However, whereas in this study, there
was evidence of compartmentalization in the majority of AGMs
both before and after removing monotypic sequences from anal-
ysis, in previous studies in rhesus monkeys (18) and humans (19,
29), only limited compartmentalization was observed. The AGM
breastmilk compartmentmay bemore permeable to viral lineages
than that of humans and rhesus monkeys, where there is a greater
degree of intermingling between the peripheral and breast milk
compartment. Therefore, the transient compartmentalization of
milk virus variants in AGMs could reflect the clonal expansion of
a more restricted diversity of milk virus variants in the low-level
CD4 T lymphocyte target cell environment (Fig. 2).
Lack of a signature SIV env sequence or unique SIV Env phe-
notype among AGM breast milk virus variants. The anatomic
compartmentalization ofmilk virus variants inAGMswarrants an
analysis of the differential genotypic and phenotypic characteris-
tics of AGM milk virus variants. We analyzed env gene sequence
alignments for each AGM at 5 months (see Fig. S1 in the supple-
mental material) and 1 year (see Fig. S2) postinfection using Los
AlamosNational Laboratory’s highlighter plot analysis tool to ob-
serve sequence attributes common to milk viruses among dis-
tinct animals. Furthermore, we mapped the location and
calculated the frequency of nonsynonymous substitutions
throughout the Env protein (Fig. 5). Using Los Alamos Na-
tional Laboratory’s sequence locator tool (30), the Env variable
regions of SIVsab92018ivTF were located according to those pre-
viously defined in SIV Mne CL8, a molecular clone of SIV (31).
There was a high frequency of nonsynonymous substitutions lo-
cated in the V1 and V2 loop regions in both plasma and milk env
variants. However, there was no single env gene signature se-
quence that was shared among the milk virus variants across the
monkeys and was not found in plasma virus variants. Interest-
ingly, at 5months postinfection therewere a few substitutions that
appeared relatively consistently among the milk virus variants
within each animal that were absent in plasma virus variants
(N358S in monkey 89, S127P in monkey 91, Q407R in monkey
92). However, these substitutions did not persist at 1 year postin-
fection. Therefore, the distinct nonsynomymous substitutions of
milk virus variants at a single time point may reflect selection of
TABLE 1 Number of clonally amplified virus variants in plasma and
breast milk virus variants of SIV-infected AGMs
Monkey Sample type
No. of amplicons
that are part of a
group of
identical
sequences
Total no.
of Env
sequences
% of Env
sequences
that are
part of a
group of
identical
sequences
P value
from
Fisher’s
exact test
89 Plasma 13 19 68.4 0.1274
Breast milk 18 20 90.0
91 Plasma 2 18 11.1 0.0001
Breast milk 15 17 88.2
92 Plasma 7 19 36.8 0.0001
Breast milk 18 18 100
93 Plasma 2 17 11.8 0.2245
Breast milk 5 16 31.3
94 Plasma 2 18 11.1 1
Breast milk 0 8 0
FIG 4 Maximum-likelihood trees of plasma and breast milk virus variants from 5months postinfection and 1 year postinfection. Trees show full-length SIV env
sequences from plasma (red squares) and milk (blue circles) at 5 months postinfection and plasma (pink squares) and milk (light blue circles) at 1 year
postinfection. There was transient compartmentalization of virus variants in the breast milk of SIV-infected AGMs, but milk virus variants do not evolve
distinctly from that in plasma over time. There were large groups of identical or nearly identical sequences among the breast milk virus variants. The scale bars
represent 0.001 nuclear substitutions per site.
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virus variants inmilk that evolve from a limited number of plasma
virus variants crossing the mammary gland epithelial cell barrier.
To predict potential phenotypic differences in the Env glyco-
protein of breastmilk and plasma viruses, we investigatedwhether
there were differences in the number of N-linked glycosylation
sites or the length of the env gene between the plasma and milk
virus variants. Neutralization escape of HIV/SIV has been previ-
ously associated with a high number of glycosylation sites and
deletions in the external regions of the Env protein which come in
contact with Env-specific antibodies (32). We used Los Alamos
National Laboratory’s N-GlycoSite tool (32) to tally the number
of predicted N-linked glycosylation sites within each env se-
quence. Themedian numbers of predictedN-linked glycoslyation
sites of plasma and milk virus variants were not different between
the two compartments (Table 2) (P 0.32). Similarly, there was
no difference in the lengths of the Env amino acid sequences of
plasma and milk virus variants (Table 2) (P 0.5).
We next assessed whether there was evidence of positive selec-
tion acting on the breast milk sequences compared to the plasma
sequences. The Codeml program implemented in PAML (33) was
used to calculate the percentage of codons in the SIV env that were
under negative, neutral, or positive selection. The ratio of the non-
synonymous substitution rate to the synonymous substitution
rate () indicates the presence of negative (  0), neutral ( 
0), or positive (  1) selection. There was evidence of positive
selection onmilk env sequences in two of five of themonkeys, with
2.3% of the env codons in monkey 91 ( 28.3) and 2.2% of the
env codons inmonkey 92 ( 11.1) exhibiting positive selection.
However, the sites of positive selection did not overlap in the two
monkeys and did not appear to locate to particular regions of the
Env, further suggesting that there is no distinct evolution of breast
milk variants.
Finally, in order to assess whether evolutionary rates differed
between the plasma and breast milk lineages, we applied the
Bayesian Markov chain Monte Carlo (MCMC) method, imple-
mented by BEAST v1.7.5 (34), to analyze the evolutionary rate of
FIG 5 Nonsynonymous amino acid substitutions in breast milk (BM) and plasma (PL) Env variants of SIV-infected AGMs. The frequencies of substitutions in
plasma virus variants and breast milk virus variants at each amino acid position in the SIVsab92018ivTF Env are shown. There is minimal clustering of
substitutions in breast milk virus variants to a specific region of the Env that is distinct from those in plasma across the five monkeys. High-frequency
substitutions in both plasma and milk virus variants are clustered in the V1 and V2 loop regions.
TABLE 2 Number of N-linked glycosylation sites and the amino acid
length of the Env in plasma and breast milk virus variants of SIV-
infected AGMsa
Monkey
Mo
postinfection Sample type
No. of N-linked
glycosylation
sites
Env amino acid
length
Median Range Median Range
89 5 Plasma 23 23–24 868 867–869
5 Breast milk 23 23–24 868 868
91 5 Plasma 24 23–25 868 864–872
5 Breast milk 23 22–24 868 867–870
12 Plasma 22 21–24 868 863–870
12 Breast milk 23 23 865 863–865
92 5 Plasma 24 24 867 866–869
5 Breast milk 23 22–24 867 867–869
12 Plasma 23 22–24 868 865–870
12 Breast milk 24 22–24 868 866–869
93 5 Plasma 23 22–24 868 866–868
5 Breast milk 23.5 23–24 866.5 866–870
94 5 Plasma 23 23–24 868 867–873
5 Breast milk 24 23–24 868 868
a P 0.32 and P 0.5 (Wilcoxon signed-rank test) for N-linked glycosylation site and
Env amino acid length data, respectively.
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the SIV env in the two monkeys for which samples were collected
at both 5 months and 1 year postinfection.
BEAST was run with the following parameters: no coalescent
model; uncorrelated lognormal relaxed clock; GTR substitution
model; root height 7 to 12.5 months; 50,000,000 MCMC itera-
tions; sampling every 5,000 steps.Wemanually inspected the trace
to ensure convergence. The burn-in was set at 10% of the total
number of iterations, and all parameters had an effective sample
size (ESS) greater than 300. The substitution rate for the SIVsab
env ofmilk and plasma virus variants ranged between 2.81 103
and 4.07 103 nucleotide substitutions per site per year, which
is consistent with previously reported SIVagm substitution rates
(35). Although the substitution rate on the branch leading to the
major breast milk lineage at 1 year postinfection is slightly higher
than that on branches leading to plasma virus variants, there was
no consistent pattern to suggest evidence that the breastmilk virus
lineage evolved at a higher rate (see Fig. S3 in the supplemental
material). Together, these observations suggest that plasma and
milk viruses likely evolve under the same selective pressure.
In summary, the breast milk virus variants in SIV-infected
AGMs are largely compartmentalized from that in blood, which is
in contrast to the limited compartmentalization previously de-
scribed in the human and rhesus monkey HIV/SIV hosts (18, 19,
29). However, the lack of distinct breast milk substitutions that
persist longitudinally and the lack of phenotypic differences be-
tween the plasma and breast milk sequences support the model of
stochastic migration and subsequent local replication of plasma
virus variants in the mammary gland. While this model has been
previously observed in humans and rhesus monkeys as well (18,
19), the low number of CD4 T lymphocyte target cells in the
breast milk compartment of AGMs may contribute to a more
limited diversity of milk virus variants and subsequently a greater
degree of compartmentalization. As only a limited number ofma-
ternal HIV variants are postnatally transmitted to infants (7, 36,
37), it is possible that the restricted diversity of AGM milk virus
variants limits the number of virus variants fit for transmission
across the genetic bottleneck introduced by themucosal barrier of
the infant gastrointestinal tract. The restricted diversity of milk
variants and the limited number of CCR5-expressingCD4 target
cells in infant AGMs (5, 38) may together contribute to the rarity
of breast milk transmission in natural hosts. Future investigations
should delve into the fitness, neutralization sensitivity, and infec-
tivity of thesemilk viruses in low-level CCR5-expressing target cell
populations to determine the contribution of the restricted virus
population in breast milk of AGMs to the rarity of infant virus
transmission in natural SIV hosts.
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